Bicara Therapeutics (BCAX) Other financing activities (2024 - 2026)
Bicara Therapeutics (BCAX) posted quarterly Other financing activities of $1.6 million for Q1 2026, up 243.91% year-over-year from $460000.0 in Q1 2025, and down 8.66% quarter-over-quarter from $1.7 million in Q4 2025.
Bicara Therapeutics (BCAX) Other financing activities (2024 - 2026) Analysis & Trends
Bicara Therapeutics' Other financing activities history runs 3 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Other financing activities rose 243.91% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $3.9 million (up 101.61% YoY), while the FY2025 annual figure was $2.8 million, up 72.26% from the prior year.
- Other financing activities for Q1 2026 stood at $1.6 million, down from $1.7 million in the prior quarter.
- The five-year high for Other financing activities was $1.7 million in Q4 2025, with the low at $60000.0 in Q3 2024.
- The 3-year median for Other financing activities is $436000.0 (2025), against an average of $661000.0.
- Peak annual rise in Other financing activities reached 2149.35% in 2025, while the deepest fall reached 89.85% in 2025.
- Bicara Therapeutics' Other financing activities stood at $77000.0 in 2024, then surged by 2149.35% to $1.7 million in 2025, then fell by 8.66% to $1.6 million in 2026.
- Business Quant data shows BCAX's Other financing activities at $1.6 million in Q1 2026, $1.7 million in Q4 2025, and $436000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Bicara Therapeutics | 1.60 Bn | 1.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33 Mn |
| Jun 30, 2026 | 2.33 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 436,000.00 |
| Sep 30, 2025 | 436,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Mar 31, 2025 | 460,000.00 |
| Mar 31, 2025 | 460,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 60,000.00 |
| Sep 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 137,000.00 |
| Mar 31, 2024 | 137,000.00 |